ATE309804T1 - Foerderung der wundheilung durch chemisch modifizierte tetracycline - Google Patents

Foerderung der wundheilung durch chemisch modifizierte tetracycline

Info

Publication number
ATE309804T1
ATE309804T1 AT97935248T AT97935248T ATE309804T1 AT E309804 T1 ATE309804 T1 AT E309804T1 AT 97935248 T AT97935248 T AT 97935248T AT 97935248 T AT97935248 T AT 97935248T AT E309804 T1 ATE309804 T1 AT E309804T1
Authority
AT
Austria
Prior art keywords
activity
wound healing
capacity
epithelialized tissue
healing
Prior art date
Application number
AT97935248T
Other languages
English (en)
Inventor
Nungavaram S Ramamurthy
Lorne M Golub
Thomas F Mcnamara
Original Assignee
Univ New York State Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ New York State Res Found filed Critical Univ New York State Res Found
Application granted granted Critical
Publication of ATE309804T1 publication Critical patent/ATE309804T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/44—Medicaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
    • A61L2300/406—Antibiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/41—Anti-inflammatory agents, e.g. NSAIDs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/412—Tissue-regenerating or healing or proliferative agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Materials Engineering (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT97935248T 1996-08-01 1997-08-01 Foerderung der wundheilung durch chemisch modifizierte tetracycline ATE309804T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/691,135 US5827840A (en) 1996-08-01 1996-08-01 Promotion of wound healing by chemically-modified tetracyclines
PCT/US1997/013534 WO1998005340A1 (en) 1996-08-01 1997-08-01 Promotion of wound healing by chemically-modified tetracyclines

Publications (1)

Publication Number Publication Date
ATE309804T1 true ATE309804T1 (de) 2005-12-15

Family

ID=24775298

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97935248T ATE309804T1 (de) 1996-08-01 1997-08-01 Foerderung der wundheilung durch chemisch modifizierte tetracycline

Country Status (11)

Country Link
US (1) US5827840A (de)
EP (1) EP0923378B1 (de)
JP (1) JP2000516214A (de)
KR (1) KR100494206B1 (de)
AT (1) ATE309804T1 (de)
AU (1) AU3823497A (de)
CA (1) CA2261805C (de)
DE (1) DE69734661T2 (de)
DK (1) DK0923378T3 (de)
ES (1) ES2255107T3 (de)
WO (1) WO1998005340A1 (de)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6015804A (en) * 1998-09-11 2000-01-18 The Research Foundation Of State University Of New York Method of using tetracycline compounds to enhance interleukin-10 production
AU775500B2 (en) 1999-05-27 2004-08-05 Euro-Celtique S.A. Preparations for the application of anti-infective and/or anti-inflammatory agents
US7300667B1 (en) 1999-05-27 2007-11-27 Euro-Celtique, S.A. Preparations for the application of anti-inflammatory, especially antiseptic agents and/or agents promoting the healing of wounds, to the lower respiratory tract
DK1212050T3 (da) * 1999-09-14 2007-02-26 Mucosal Therapeutics Llc Formuleringer indeholdende tetracycliner til behandling eller forebyggelse af mucositis
EP1829546A1 (de) * 1999-09-14 2007-09-05 Mucosal Therapeutics LLC Formulierungen zur Behandlung oder Vorbeugung von Mucositis
US6946118B1 (en) 1999-09-14 2005-09-20 Orapharma, Inc. Formulations for treating or preventing mucositis
EP1296703B1 (de) * 2000-06-02 2005-02-09 Yu Liu Nicht-antibakterielle tetrazykline als anti-pilz medikamente
US7211267B2 (en) * 2001-04-05 2007-05-01 Collagenex Pharmaceuticals, Inc. Methods of treating acne
NZ529308A (en) * 2001-04-05 2005-03-24 Collagenex Pharm Inc Tetracycline compounds comprising a tetracycline and a controlled release agent to provide delivery at a dose below that required for antibiotic activity
EP2221056A1 (de) * 2001-04-05 2010-08-25 Collagenex Pharmaceuticals, Inc. Tetracyklin-derivate zur Behandlung von Akne
US20060194773A1 (en) * 2001-07-13 2006-08-31 Paratek Pharmaceuticals, Inc. Tetracyline compounds having target therapeutic activities
EP2301915A1 (de) 2001-07-13 2011-03-30 Paratek Pharmaceuticals, Inc. 7-(diethylamino)methyl substituierte Tetracycline mit therapeutischen Targetwirkungen
EP1439855A4 (de) * 2001-09-25 2009-02-11 Quick Med Technologies Inc Zusammensetzung und verfahren zur minimierung oder vermeidung von unerwünschten vesikans-wirkungen
AU2002357370A1 (en) * 2001-12-20 2003-07-09 Hartmut M. Hanauske-Abel Treatment for averting or delaying premature delivery
EP2311797A1 (de) 2002-01-08 2011-04-20 Paratek Pharmaceuticals, Inc. 4-Dedimethylamin-Tetracyclinverbindungen
CN102531948A (zh) 2002-03-08 2012-07-04 帕拉特克药品公司 氨基-甲基取代的四环素类化合物
WO2003079984A2 (en) 2002-03-21 2003-10-02 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds
US8192749B2 (en) 2003-04-16 2012-06-05 Galderma Laboratories Inc. Methods of simultaneously treating ocular rosacea and acne rosacea
US7008631B2 (en) * 2002-04-16 2006-03-07 Collagenex Pharmaceuticals, Inc. Methods of simultaneously treating ocular rosacea and acne rosacea
AU2003243205A1 (en) * 2002-05-06 2003-11-17 Collagenex Pharmaceuticals, Inc. Methods of simultaneously treating mucositis and fungal infection
EP1534300A4 (de) 2002-07-12 2008-04-23 Paratek Pharm Innc 3, 10, und 12a substituierte tetracyclin-verbindungen
KR20050034713A (ko) * 2002-07-12 2005-04-14 더 리서치 파운데이션 오브 스테이트 유니버시티 오브 뉴욕 비-항균성 테트라사이클린 제형을 사용하여 ｃ-반응성단백질 수준을 감소시키는 방법
US20080139512A1 (en) * 2002-09-25 2008-06-12 Quick-Med Technologies, Inc. Method for minimizing or avoiding adverse effects of vesicants
PT1615622E (pt) 2003-04-07 2012-10-17 Supernus Pharmaceuticals Inc Formulações de doxiciclinas de dose única diária
JP4738333B2 (ja) 2003-07-09 2011-08-03 パラテック ファーマシューティカルズ インコーポレイテッド ９−アミノメチルテトラサイクリン化合物のプロドラッグ
EP2298323A3 (de) 2003-07-09 2011-05-11 Paratek Pharmaceuticals, Inc. Substituierte Tetracyclin-Verbindungen
JP2007510757A (ja) * 2003-11-06 2007-04-26 ザ リサーチ ファウンデーション オブ ステイト ユニヴァーシティ オブ ニューヨーク 湿疹の治療方法
EP1716101A1 (de) * 2004-01-15 2006-11-02 Paratek Pharmaceuticals, Inc. Derivate von tetracyclinverbindungen mit aromatischem a-ring
EP2284150A3 (de) 2004-10-25 2011-09-21 Paratek Pharmaceuticals, Inc. Substituierte Tetracyclin-Verbindungen
EP2301916A3 (de) 2004-10-25 2011-09-28 Paratek Pharmaceuticals, Inc. 4-Aminotetracycline und Verfahren zu ihrer Verwendung
US20060252731A1 (en) * 2005-05-06 2006-11-09 Pfeiffer David F Methods of treating recurrent aphthous stomatitis
JP2009502809A (ja) * 2005-07-21 2009-01-29 パラテック ファーマシューティカルズ インコーポレイテッド １０−置換テトラサイクリンおよびその使用方法
KR101538175B1 (ko) 2006-12-21 2015-07-20 파라테크 파마슈티컬스, 인크. 박테리아, 바이러스 및 기생충 감염의 치료를 위한 테트라시클린 유도체
US8513223B2 (en) * 2006-12-21 2013-08-20 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds for treatment of inflammatory skin disorders
EP2144870A2 (de) * 2007-04-27 2010-01-20 Paratek Pharmaceuticals, Inc. Verfahren zur synthese und reinigung von aminoalkyl-tetracyclin-verbindungen
EP2192111A3 (de) * 2007-07-06 2010-10-06 Paratek Pharmaceuticals, Inc. Verfahren zur Synthese substituierter Tetracyclinverbindungen
TW202332671A (zh) * 2008-05-23 2023-08-16 美商Ｐｒｔｋ Ｓｐｖ２公司 四環素化合物之甲苯磺酸鹽及同素異形體
NZ603568A (en) 2008-08-08 2014-05-30 Tetraphase Pharmaceuticals Inc C7-fluoro substituted tetracycline compounds
DK2427425T3 (en) 2009-05-08 2017-06-12 Tetraphase Pharmaceuticals Inc tetracycline
CN102596898B (zh) 2009-08-28 2016-01-27 四相制药公司 四环素类化合物
DK2552890T3 (en) 2010-03-31 2017-04-03 Tetraphase Pharmaceuticals Inc POLYCYCLIC TETRACYCLINE COMPOUNDS
NZ705849A (en) 2012-08-31 2018-06-29 Tetraphase Pharmaceuticals Inc Tetracycline compounds
CN104307031B (zh) * 2014-11-10 2015-12-30 刘维峰 一种皮肤外用修复材料的制备方法及用途
DK3529236T3 (da) 2016-10-19 2024-05-13 Tetraphase Pharmaceuticals Inc Krystalformer af eravacyclin
WO2020097450A1 (en) 2018-11-09 2020-05-14 Tetraphase Pharmaceuticals, Inc. Polymorphic forms of a compound and uses thereof

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1767900U (de) * 1958-03-27 1958-06-04 Herbert Dipl Ing Fritzsche Hand- oder taschenleuchte mit blinker.
US3823212A (en) * 1968-11-27 1974-07-09 Freudenberg C Fa Process for the production of collagen fiber fabrics in the form of felt-like membranes or sponge-like layers
US4016877A (en) * 1976-02-23 1977-04-12 Avicon, Inc. Fibrous collagen derived web having hemostatic and wound sealing properties
US4294241A (en) * 1977-06-09 1981-10-13 Teruo Miyata Collagen skin dressing
US4130555A (en) * 1977-09-06 1978-12-19 Nippi Incorporated Peptide mixtures derived from collagenous material or gelatin
US4412947A (en) * 1979-09-12 1983-11-01 Seton Company Collagen sponge
US4440680A (en) * 1980-09-24 1984-04-03 Seton Company Macromolecular biologically active collagen articles
DE3037513C2 (de) * 1980-10-03 1983-05-05 Steffan, Wolfgang, 8425 Neustadt Kollagene Wundauflage
US4578067A (en) * 1982-04-12 1986-03-25 Alcon (Puerto Rico) Inc. Hemostatic-adhesive, collagen dressing for severed biological surfaces
US4666897A (en) * 1983-12-29 1987-05-19 Research Foundation Of State University Inhibition of mammalian collagenolytic enzymes by tetracyclines
US4925833A (en) * 1983-12-29 1990-05-15 The Research Foundation Of State University Of New York Use of tetracycline to enhance bone protein synthesis and/or treatment of osteoporosis
US4935412A (en) * 1983-12-29 1990-06-19 The Research Foundation Of State University Of New York Non-antibacterial tetracycline compositions possessing anti-collagenolytic properties and methods of preparing and using same
US4704383A (en) * 1983-12-29 1987-11-03 The Research Foundation Of State University Of New York Non-antibacterial tetracycline compositions possessing anti-collagenolytic properties and methods of preparing and using same
US4837024A (en) * 1984-02-24 1989-06-06 The Regents Of The University Of California Compositions, articles and mehtod for improving wound healing
US4837285A (en) * 1984-03-27 1989-06-06 Medimatrix Collagen matrix beads for soft tissue repair
IT1181737B (it) * 1985-11-26 1987-09-30 Pierfrancesco Morganti Supproto di collagene biologicamente attivo per uso cosmetico e farmaceutico e metodo per prepararlo
US5196196A (en) * 1986-06-03 1993-03-23 Incyte Pharmaceuticals, Inc. Use of protease nexin-I in wound dressings
US4813942A (en) * 1987-03-17 1989-03-21 Bioderm, Inc. Three step wound treatment method and dressing therefor
US4969912A (en) * 1988-02-18 1990-11-13 Kelman Charles D Human collagen processing and autoimplant use
US4950483A (en) * 1988-06-30 1990-08-21 Collagen Corporation Collagen wound healing matrices and process for their production
US5024841A (en) * 1988-06-30 1991-06-18 Collagen Corporation Collagen wound healing matrices and process for their production
US5110604A (en) * 1988-06-30 1992-05-05 Collagen Corporation Processes for producing collagen matrixes and methods of using same
GB8827305D0 (en) * 1988-11-23 1988-12-29 British Bio Technology Compounds
US5227168A (en) * 1989-11-21 1993-07-13 Bruce Barber Method of treating a wound
JP3016587B2 (ja) * 1989-12-04 2000-03-06 ザ・リサーチ・ファンデーション・オブ・ステート・ユニバーシティ・オブ・ニューヨーク 非ステロイド抗炎症剤及びテトラサイクリンの配合
US5308839A (en) * 1989-12-04 1994-05-03 The Research Foundation Of State University Of New York Composition comprising non-steroidal anti-inflammatory agent tenidap and effectively non-antibacterial tetracycline
GB9000846D0 (en) * 1990-01-15 1990-03-14 Beecham Group Plc Novel compounds
US5008283A (en) * 1990-03-19 1991-04-16 Pfizer Inc. Use of tenidap to inhibit activation of collagenase and to inhibit the activity of myeloperoxidase
GB9008065D0 (en) * 1990-04-10 1990-06-06 Beecham Group Plc Novel compounds
US5081106A (en) * 1990-07-16 1992-01-14 The Oregon Health Sciences University Wound dressing protocol utilizing collagen gelatin formed with iodine
US5156601A (en) * 1991-03-20 1992-10-20 Hydromer, Inc. Tacky, hydrophilic gel dressings and products therefrom
US5229380A (en) * 1991-06-28 1993-07-20 Harris Richard Y Method for treating helicobacter pylori gastritis
US5258371A (en) * 1992-05-29 1993-11-02 Kuraray Co., Ltd. Method to reduce connective tissue destruction
DE69304292T2 (de) * 1992-11-17 1997-01-02 Univ New York Tetracycline inclusive nicht antimicrobiel wirksame, chemisch modifizierte Tetracycline hemmende exzessive Kollagenquervernetzung bei Diabetes

Also Published As

Publication number Publication date
CA2261805A1 (en) 1998-02-12
JP2000516214A (ja) 2000-12-05
US5827840A (en) 1998-10-27
EP0923378A1 (de) 1999-06-23
EP0923378B1 (de) 2005-11-16
KR20000029753A (ko) 2000-05-25
DK0923378T3 (da) 2006-04-03
AU3823497A (en) 1998-02-25
DE69734661T2 (de) 2006-08-10
KR100494206B1 (ko) 2005-06-13
EP0923378A4 (de) 2000-11-15
CA2261805C (en) 2008-11-04
ES2255107T3 (es) 2006-06-16
DE69734661D1 (de) 2005-12-22
WO1998005340A1 (en) 1998-02-12

Similar Documents

Publication Publication Date Title
ATE309804T1 (de) Foerderung der wundheilung durch chemisch modifizierte tetracycline
DK0489032T3 (da) Hydroxaminsyre-baserede kollagenaseinhibitorer
DE69937562D1 (de) Verbessertes angereichertes blutplättchen wundheilmittel
ATE512650T1 (de) Hydrogelwundverband und zugehöriges herstellungs- und benutzungsverfahren
ES2187665T3 (es) Uso de la il-10 para curar heridas con una cicatrizacion reducida.
ATE196604T1 (de) Zusammensetzung enthaltend pdgf und dexamethason zur förderung von gewebsreparatur und - regenerierung
ES2155135T3 (es) Aposito en forma de gel para heridas.
PT784481E (pt) Formulacoes para cicatrizacao de feridas contendo fibronectina do plasma humano
DE60138549D1 (de) Topische gel-abgabesysteme zur behandlung von hauterkrankungen
ATE339187T1 (de) Verwendung von zusammensetzungen mit antiseptika und/oder die wundheilung fördernden wirkstoffen für den tieferen atemwegstrakt
RU2007118663A (ru) Способ применения адапалена при поддерживающей терапии угревой сыпи
DE60142632D1 (de) Heilung von wunden
ATE226084T1 (de) Wundheilung und behandlung von fibrose
ATE471985T1 (de) Protease from lucilia sericata und deren verwendung zur wundheilung
KR101987332B1 (ko) 여드름 피부 완화 얼굴마스크
ATE113209T1 (de) Verwendung von 5-amino-salicylsäure für die behandlung von hautkrankheiten.
DK0951294T3 (da) Sårhelende formuleringer indeholdende humanplasmafibronectin
DE69528573D1 (de) Verwendung einer Zubereitung enthaltend einen Plasminogen-Aktivator für die Verbesserung der Wundheilung
PT1115375E (pt) Utilizacao de pelo menos um derivado do acido 10-hidroxi-2-decenoico numa composicao destinada a favorecer a descamacao da pele
MY143194A (en) Topical pharmaceutical compositions for healing wounds
ATE234110T1 (de) Komponente b als wundheilendes mittel
ITPD920102A1 (it) Composizione farmaceutica utile per trattare malattie gastroenteriche, ferite e ustioni e come agente emostatico
RU2000106839A (ru) Способ лечения фурункулов лица
HARPER Wound healing and connective tissue metabolism: The role of hyperbaric oxygen therapy(Final Report, 1 Jul. 1991- 30 Jun. 1992)
Demidov et al. Helium-neon laser in prophylaxis of suppuration and treatment of operative purulent wounds in tuberculous patients.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0923378

Country of ref document: EP